Brilliant Violet 421™ anti-human CD158/h (KIR2DL1/KIR2DS1) Antibody, CD158a/h, S22013A,BioLegend,317114

Clone S22013A can block the binding of clone HP-DM1 on target cells and is not blocked by HP-DM1.Based on in-house testing on different KIR-expressing transfectants, clone S22013A does not interact with other KIR protein family members.

Host

Mouse

Reactivity

Human

Application

FC - Quality tested

Platform ID

BAB137012347

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameBrilliant Violet 421™ anti-human CD158/h (KIR2DL1/KIR2DS1) Antibody, CD158a/h, S22013A
Cat. No.317114
HostMouse
RRIDAB_3720564 (BioLegend Cat. No. 317113)AB_3720564 (BioLegend Cat. No. 317114)
IsotypeMouse IgG1, κ
ReactivityHuman
ApplicationFC - Quality tested
ClonalityMonoclonal
Clone NumberS22013A
ConcentrationLot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysisonline tool).
TargetCD158a CD158h
ImmunogenHuman KIR2DS1 transfected cells
PurityThe antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421™ under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
StorageThe antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

CD158 molecules, also known as KIRs (killer cell immunoglobulin-like receptors), are a family of transmembrane proteins with either two (KIR2D) or three (KIR3D) Ig-like extracellular domains. Some KIRs with long cytoplasmic domains contain ITIMs and possess inhibitory functions and others with short cytoplasmic region lack ITIM and have activation functions. Fifteen polymorphic KIR genes have been reported in humans.CD158a and CD158h are 38-50 kD two extracellular Ig domain single-pass glycoprotein that contains a short cytoplasmic tail for KIR2DL1. It is expressed primarily on a subset of NK cells and a subset of T cells. KIR2DL1 and KIR2DS1 have been reported to bind certain HLA-C antigens on target cells (HLA-C*02, HLA-C*04, HLAC*06, for example).

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.